3 month semaglutide program (Any Dose) 3-Month GLP-1 Weight Loss Program

This narrative review summarises the role of incretin mimetics, individually or in combination therapy, in the treatment of MASLD/MASHhighlighting the pathophysiology and mechanisms of action, recent evidence from phase 2 and 3 MASH clinical trials, and clinical benefits

So a 12.5% deficit at your starting weight becomes a smaller deficit at a lower weight, even if your eating stays exactly the same

This is why the CDMO (Contract Development and Manufacturing Organization) landscape matters enormously

All trademarks, product names, and brand names referenced in this article belong to their respective owners and are used for identification and nominative reference only

Many people have never measured their resting heart rate accurately and are surprised by their starting point

So how do we, as a community of researchers, healthcare professionals and patient advocates, better reach those at the margins - particularly people who may not be connected to large patient organisations, specialist services or well-connected networks